Prognostic impact of the 21-gene recurrence score (RS) on disease-free and overall survival of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant chemotherapy: Results from NSABP B-28.

被引：0
|
作者：
Mamounas, Eleftherios P.
Tang, Gong
Paik, Soonmyung
Baehner, Frederick L.
Liu, Qing
Jeong, Jong-Hyeon
Kim, Seong-Rim
Butler, Steven M.
Jamshidian, Farid
Cherbavaz, Diana B.
Shak, Steven
Julian, Thomas B.
Lembersky, Barry C.
Wickerham, D. Lawrence
Costantino, Joseph P.
Wolmark, Norman
机构：
[1] Natl Surg Adjuvant Breast & Bowel Project, Canton, OH USA
[2] Aultman Hosp, Canton, OH USA
[3] NSABP Biostat Ctr, Pittsburgh, PA USA
[4] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[5] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA
[6] Genom Hlth, Redwood City, CA USA
[7] Natl Surg Adjuvant Breast & Bowel Project, Ctr Biostat, Pittsburgh, PA USA
[8] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[9] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA
[10] NSABP, Pittsburgh, PA USA
[11] Allegheny Gen Hosp, Allegheny Canc Ctr, Pittsburgh, PA 15212 USA
[12] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 27期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association between the 21-gene recurrence score (RS) and benefit from adjuvant paclitaxel (Pac) in node-positive (N plus ), ER-positive breast cancer patients (pts): Results from NSABP B-28
    Mamounas, E. P.
    Tang, G.
    Paik, S.
    Baehner, F. L.
    Liu, Q.
    Jeong, J-H
    Kim, S-R
    Butler, S. M.
    Jamshidian, F.
    Cherbavaz, D. B.
    Sing, A. P.
    Shak, S.
    Julian, T. B.
    Lembersky, B. C.
    Wickerham, D. L.
    Costantino, J. P.
    Wolmark, N.
    CANCER RESEARCH, 2012, 72
  • [2] 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
    Mamounas, Eleftherios P.
    Liu, Qing
    Paik, Soonmyung
    Baehner, Frederick L.
    Tang, Gong
    Jeong, Jong-Hyeon
    Kim, S. Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Sing, Amy P.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (04):
  • [3] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Gong Tang
    Steven Shak
    Soonmyung Paik
    Stewart J. Anderson
    Joseph P. Costantino
    Charles E. Geyer
    Eleftherios P. Mamounas
    D. Lawrence Wickerham
    Norman Wolmark
    Breast Cancer Research and Treatment, 2011, 127 : 133 - 142
  • [4] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Tang, Gong
    Shak, Steven
    Paik, Soonmyung
    Anderson, Stewart J.
    Costantino, Joseph P.
    Geyer, Charles E., Jr.
    Mamounas, Eleftherios P.
    Wickerham, D. Lawrence
    Wolmark, Norman
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 133 - 142
  • [5] Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer
    Poorvu, Philip D.
    Gelber, Shari, I
    Rosenberg, Shoshana M.
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Collins, Laura C.
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia F.
    Come, Steven E.
    Warner, Ellen
    Jakubowski, Debbie M.
    Russell, Christy
    Winer, Eric P.
    Partridge, Ann H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 725 - +
  • [6] Association between the 21-gene recurrence score assay (RS) and risk of locoregional failure in node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
    Mamounas, E
    Tang, G
    Bryant, J
    Paik, S
    Shak, S
    Costantino, J
    Watson, D
    Wickerham, DL
    Wolmark, N
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S16 - S16
  • [7] The 21-gene Recurrence Score (RS) Predicts Risk of Loco-regional Recurrence (LRR) in Node (+), ER (+) Breast Cancer (BC) after Adjuvant Chemotherapy and Tamoxifen: Results from NSABP B-28
    Mamounas, E. P.
    Tang, G.
    Paik, S.
    Baehner, F. L.
    Liu, Q.
    Jeong, J.
    Kim, S.
    Butler, S. M.
    Jamshidian, F.
    Cherbavaz, D. B.
    Sing, A. P.
    Shak, S.
    Julian, T. B.
    Lembersky, B. C.
    Wickerham, D. L.
    Costantino, J. P.
    Wolmark, N.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S6 - S6
  • [8] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal, node-positive, ER-positive breast cancer (S8814, INT0100)
    Albain, K.
    Barlow, W.
    Shak, S.
    Hortobagyi, G.
    Livingston, R.
    Yeh, I.
    Ravdin, P.
    Yoshizawa, C.
    Baehner, F.
    Davidson, N.
    Sledge, G.
    Winer, E.
    Hudis, C.
    Ingle, J.
    Perez, E.
    Pritchard, K.
    Shepherd, L.
    Allred, C.
    Osborne, K.
    Hayes, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 585 - 585
  • [9] The 21-Gene Recurrence Score Influences Treatment Recommendations for Patients With Node-Positive Breast Cancer
    Millien, Jeffanne
    Edwards, Claire
    Kaltman, Rebecca
    McSwain, Anita P.
    McGrail, Lisa
    Teal, Christine B.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 82 - 83
  • [10] Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor-positive, Node-positive Breast Cancer
    Brufsky, Adam M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (04): : 404 - 410
12345